Pharma 'missing an opportunity with remote monitoring technologies'
This article was originally published in SRA
Executive Summary
Pharmaceutical companies, medicine regulators and healthcare systems are missing an opportunity with remote drug monitoring and other technologies that have the potential to boost patient adherence to drugs and increase the efficacy of medicines.